Cargando…
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
In the absence of a correlate(s) of protection against human tuberculosis and a validated animal model of the disease, tools to facilitate vaccine development must be identified. We present an optimised ex vivo mycobacterial growth inhibition assay (MGIA) to assess the ability of host cells within t...
Autores principales: | Painter, Hannah, Prabowo, Satria A., Cia, Felipe, Stockdale, Lisa, Tanner, Rachel, Willcocks, Samuel, Reljic, Rajko, Fletcher, Helen A., Zelmer, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039920/ https://www.ncbi.nlm.nih.gov/pubmed/32094451 http://dx.doi.org/10.1038/s41598-020-60223-y |
Ejemplares similares
-
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
por: Prabowo, Satria A., et al.
Publicado: (2019) -
Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
por: Prabowo, Satria A., et al.
Publicado: (2019) -
High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2018) -
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016) -
The Antimicrobial Peptide, Bactenecin 5, Supports Cell-Mediated but Not Humoral Immunity in the Context of a Mycobacterial Antigen Vaccine Model
por: Munshi, Tulika, et al.
Publicado: (2020)